KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elanco Animal Health (ELAN) Other Non-Current Liabilities (2017 - 2025)

Elanco Animal Health's Other Non-Current Liabilities history spans 9 years, with the latest figure at $427.0 million for Q4 2025.

  • For Q4 2025, Other Non-Current Liabilities rose 41.39% year-over-year to $427.0 million; the TTM value through Dec 2025 reached $427.0 million, up 41.39%, while the annual FY2025 figure was $427.0 million, 41.39% up from the prior year.
  • Other Non-Current Liabilities for Q4 2025 was $427.0 million at Elanco Animal Health, down from $607.0 million in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $638.0 million in Q2 2025 and bottomed at $220.0 million in Q3 2021.
  • The 5-year median for Other Non-Current Liabilities is $356.5 million (2023), against an average of $369.4 million.
  • The largest annual shift saw Other Non-Current Liabilities fell 29.69% in 2021 before it surged 93.47% in 2024.
  • A 5-year view of Other Non-Current Liabilities shows it stood at $261.0 million in 2021, then decreased by 12.26% to $229.0 million in 2022, then skyrocketed by 79.48% to $411.0 million in 2023, then dropped by 26.52% to $302.0 million in 2024, then soared by 41.39% to $427.0 million in 2025.
  • Per Business Quant, the three most recent readings for ELAN's Other Non-Current Liabilities are $427.0 million (Q4 2025), $607.0 million (Q3 2025), and $638.0 million (Q2 2025).